Intimation of participation by the officials of the Company in the Investor/Analyst Meet to be held on August 11 to 13, 2026 in Singapore & Hong Kong

August 6, 2026 To To Listing Department, The Corporate Relations Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED Exchange Plaza, Phiroz Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E), 25th floor, Dalal Street, MUMBAI -400 051 MUMBAI -400 001 Company Code No. AUROPHARMA Company Code No. 524804 Dear Sir/ Madam, Sub: Participation in Investor / Analyst meeting This is to inform you that the officials of the Company will be participating in the following investor / analyst meeting. Date Time Investor/Analyst Type of Location Meeting name meeting August 11 to 13, 2026 09:00 AM to 06:00 Nuvama India In-person Singapore & Hong PM (GMT +8) Conference 2026 – and group Kong Singapore & Hong Kong meetings The schedule of the above-mentioned meeting is subject to change and the change may occur due to exigence on the part of the Investor / Company. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. Please take the above information on record. Thanking you, Yours faithfully, For AUROBINDO PHARMA LIMITED B. Adi Reddy Company Secretary Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038 Telangana., India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com